HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Alberto Reaffirms Commitment To Skin Care With Noxzema Buy

This article was originally published in The Rose Sheet

Executive Summary

Alberto-Culver's pending acquisition of the Noxzema brand from Procter & Gamble will add a second major skin-care business to its portfolio and "reaffirm" its commitment to the category, the firm said Sept. 8

You may also be interested in...



Alberto Culver Takes Turn Attempting To "Freshen" Noxzema Image

Alberto Culver is taking measures with Noxzema to address some of the same challenges Procter & Gamble faced before divesting the iconic brand in fall 2008

Alberto Culver Takes Turn Attempting To "Freshen" Noxzema Image

Alberto Culver is taking measures with Noxzema to address some of the same challenges Procter & Gamble faced before divesting the iconic brand in fall 2008

Alberto-Culver's Noxzema Quality Issues Traced To P&G Facility; Suit Filed

A lawsuit filed by Alberto-Culver against Procter & Gamble - over the Noxzema brand each has parented - bears further testimony to quality control issues at P&G's manufacturing plant in Puerto Rico, which drew an FDA warning letter in April

Related Content

UsernamePublicRestriction

Register

RS015655

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel